Strahlentherapie und Onkologie, Journal Year: 2024, Volume and Issue: 200(11), P. 992 - 993
Published: Aug. 2, 2024
We thank Abdusalam and Kara for their insightful discussion [1] of our findings [2] appreciate the opportunity to offer thoughts.Abdusalam discuss determination sarcopenia based on planning computed tomography (CT).In doing so, we follow in a tradition high-ranking investigations that have relied upon imaging determine presence (including publications Lancet Oncology, Radiology, JAMA) [2-9].In last 4 years alone, close 40 used term "CT-defined sarcopenia" according search PubMed, including Journal Cachexia, Sarcopenia, Muscle, one most relevant journals field [10].Hence, study's imaging-based definition is well line with large body literature.We are aware an definition, while commonly used, not universally applied: An increasing number studies use definitions rely combination physical function [11,12] or alone [13,14].The need consensus remains pressing, but unmet at this time [15].There similar heterogeneity when it comes type muscle mass assessment, though even some ultrasound-based [16,17] as papers [7,11,12] refer (CT) magnetic resonance (MRI) gold standard.The undeniable advantage study setup available cranial CT scans routinely acquired radiation every glioblastoma patient.Hence, assessment can be performed without additional examinations patients.We observed strong
Language: Английский